Prdm5 loss results in decreased Collagen I and Decorin levels and leads to reduced bone formation <i>in vivo</i>. by Giorgio Giacomo Galli (165327)

Decreased reductase activity and increased round body formation in the <i>gpsA</i> mutant. by Dan Drecktrah (36180)

Increased body fat, glucose and PAI-1 and decreased adiponectin levels in 6 wk old WT offspring exposed to HF IU/L. by Patricia M. Vuguin (587226)

25OHD₃ does not induce vascular calcification in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ restores calcium and PTH levels in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Gal-9 treatment decreases levels of MMP-9, MMP-2 and TIMP-1 but not neutrophil chemoattractants in BALF. by Yuko Horio (4243405)

Ara-C treatment caused a decrease in microglia, NG2+ progenitors, oligodendrocytes, astrocytes and T cells in the spinal cord of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

VH14PEST decreases the toxicity of α-Syn as measured by a proteostatic assay with mhttex1-72QGFP. by David C. Butler (261919)

Intron 1 CpG island methylation status correlates with WT1 expression. by Gregory McCarty (708081)

Subjects:

Hypomethylation of the Intron 1 CpG island results in WT1 expression. by Gregory McCarty (708081)

Subjects:

Hypoxia diminishes DNMT expression and activity and increases expression and activity of TET2 and TET3. by Gregory McCarty (708081)

Subjects:

Avertin®-induced decrease in basal particle transport speed (PTS) remains unaffected in WT mice in the presence of TASK-1 inhibitors and in TASK-1 KO mice. by Ghulam Murtaza (2559319)

“…<p><b>(A)</b> Avertin® in the presence of anandamide did not decrease PTS significantly. …”

Decreased IL-17A production by DGKζ deficient <i>i</i>NKT cells following α-GalCer stimulation in vitro. by Jinhong Wu (424170)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

Metformin decreases CRC-like organoids viability to the same extent as current chemotherapy without significant effects on WT organoids. by Silvia Cruz-Gil (7037249)

Triiodothyroacetic acid (TRIAC), thyroxine (T4) and 3,5,3’-triiodothyronine (T3) levels in plasma of vehicle treated wild type (Wt; TRIAC n = 5; T4 n = 5; T3 n = 5 and TSH n = 4) a... by Soledad Bárez-López (607514)

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

Decreased consumption of methionine sulfoxide (MetO) by the <i>V</i>. <i>cholerae</i> Δ<i>gcvT</i> mutant attenuates virulence by promoting intestinal lipid mobilization and insuli... by Audrey S. Vanhove (4090594)

Lack of PD-L1 expression by host tissues increases numbers of activated donor T cells but decreases donor Tregs in spleen. by Mohammad S. Hossain (415643)

Loss of <i>SLC4A11</i> expression and CHED-associated <i>SLC4A11</i> mutations in hCEnC lead to decreased cell viability during tBH-induced oxidative stress. by Doug D. Chung (3611387)